TEST BANK For Edmunds' Pharmacology for the Primary Care Provider, 5th Ed
b b b b b b b b b b b
ition by Zambroski & Rebecca M Lutz | Verified Chapter's 1 -
b b b b b b b b b b b
b73 | Complete Newest Version
b b b b
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
1
,TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
2
,TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
3
,TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
4
,Chapter 01: Prescriptive Authority and Role Implementation: Tradition vs. ChangeTest B
b b b b b b b b b b b
ank
MULTIPLEbCHOICE
1. bWhichbofbthebfollowingbhasbinfluencedbanbemphasisbonbprimarybcarebeducationbinbmedicalbsc
hools?
a. ChangesbinbMedicarebreimbursementb
methodsbrecommendedbinb1992
b. Competitionbfrombnonphysiciansbdesiringbto
bmeetb primarybcarebshortages
c. Thebneedbforbmonopolisticbcontrolbinbthebm
arketplacebofbprimaryboutpatientbcare
d. Thebrecognitionbthatbnonphysiciansbhavebv
ariablebsuccessbprovidingbprimarybcare
ANS:b A
ThebPhysicianbPaymentbReviewbCommissionbinb1992bdirectlybincreasedbfinancialbreimbursem
entbtobcliniciansbwhobprovidebprimarybcare.bCoupledbwithbabshortagebofbprimarybcarebprovid
ers,bthisbincentivebledbmedicalbschoolsbtobplacebgreaterbemphasisbonbpreparingbprimarybcareb
physicians.bCompetitionbfrombnonphysiciansbincreasedbcoincidentallybasbprofessionalsbfrombo
therbdisciplinesbsteppedbupbtobmeetbthebneeds.
Nonphysiciansbhavebhadbincreasingbsuccessbatbprovidingbprimarybcarebandbhavebbeenbshownb
tobbebsafebandbeffective.
DIF: CognitivebLevel:bRememberingb(Knowledge) REF:b 2
2. Whichbofbthebfollowingbstatementsbisbtruebaboutbthebprescribingbpracticesbofbphysicians?
a. Olderbphysiciansbtendbtobprescribebmoreb
appropriatebmedicationsbthanbyoungerb
physicians.
b. Antibioticbmedicationsbremainbinbthebtopbfi
vebclassificationsbofbmedicationsbprescrib
ed.
c. Mostbphysiciansbrelybonbab“therapeuticbarm
amentarium”bthatbconsistsbofblessbthan
100bdrugbpreparationsbperbphysician.
d. Thebdominantbformbofbdrugbinformationbuse
dbbybprimarybcarebphysiciansbcontinuesbtobb
ebthatbprovidedbbybpharmaceuticalbcompa
nies.
ANS:b D
Evenbthoughbmostbphysiciansbclaimbtobplaceblittlebweightbonbdrugbadvertisements,
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
5
, pharmaceuticalbrepresentatives,bandbpatientbpreferencebandbstatebthatbtheybrelybonbacade
micbsourcesbforbdrugbinformation,babstudybshowedbthatbcommercialbratherbthanbscientificbsourc
esbofbdrugbinformationbdominatedbtheirbdrugbinformationbmaterials.bYoungerbphysiciansbtendb
tobprescribebfewerbandbmorebappropriatebdrugs.bAntibioticsbhavebdroppedboutbofbthebtopbfiv
ebclassificationsbofbdrugsbprescribed.bMostbphysiciansbhavebabtherapeuticbarmamentariumbofb
aboutb144bdrugs.
DIF: CognitivebLevel:bRememberingb(Knowledge) REF:b 3
3. Asbprimarybcarebnursebpractitionersb(NPs)bcontinuebtobdevelopbtheirbrolebasbprescribersbofbm
edications,bitbwillbbebimportantbto:
a. attainbthebsameblevelbofbexpertisebasb
physiciansb whob currentlybprescribe
medications.
b. learnbfrombthebexperiencesbofbphysiciansb
andbdevelopbexpertisebbasedbonbevidence
-bbasedbpractice.
c. maintainbcollaborativebandbsupervisorialbr
elationshipsbwithbphysiciansbwhobwillbover
seebprescribingbpractices.
d. developbrelationshipsbwithbpharmaceuticalbr
epresentativesbtoblearnbaboutbnewbmedicat
ionsbasbtheybarebdeveloped.
ANS:b B
Asbnonphysiciansbdevelopbthebrolesbassociatedbwithbprescriptivebauthority,bitbwillbbebimporta
ntbtoblearnbfrombthebpastbexperiencesbofbphysiciansbandbtobdevelopbprescribingbpracticesbba
sedbonbevidence-
basedbmedicine.bItbisbhopedbthatballbprescribers,bincludingbphysiciansbandbnursebpractitioners,
bwillbstrivebtobdobbetterbthanbinbthebpast.bNPsbshouldbworkbtowardbprescriptivebauthoritybandbf
orbpracticebthatbisbnotbsupervisedbbybanotherbprofessional.bPharmaceuticalbrepresentativesbp
rovidebinformationbthatbcarriesbsomebbias.bAcademicbsourcesbarebbetter.
DIF: CognitivebLevel:bApplyingb(Application) REF:b4
Chapter 02: Historical Review of Prescriptive Authority: The Role of Nurses (NPs,CNMs,
b b b b b b b b b b b b b
CRNAs, and CNSs) and Physician Assistants
b b b b b
Test Bank
b
MULTIPLEbCHOICE
1. AbprimarybcarebNPbwillbbeginbpracticingbinbabstatebinbwhichbthebgovernorbhasboptedboutbofbth
ebfederalbfacilitybreimbursementbrequirement.bThebNPbshouldbbebawarebthatbthisbdefinesbhow
bNPsbmaybwritebprescriptions:
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
6
, a. withoutbphysicianbsupervisionbinbprivatebpr
actice.
b. asbCRNAsbwithoutbphysicianbsupervisionbinb
abhospitalbsetting.
c. inbanybsituationbbutbwillbnotbbebreimbursedbf
orbthisbbybgovernmentb insurers.
d. onlybwithbphysicianbsupervisionbinbbothbpri
vatebpracticebandbabhospitalbsetting.
ANS:b B
Inb2001,bthebCentersbforbMedicarebandbMedicaidbServicesbchangedbthebfederalbphysicianbsu
pervisionbrulebforbCRNAsbtoballowbstatebgovernorsbtoboptbout,ballowingbCRNAsbtobwritebprescri
ptionsbandbdispensebdrugsbwithoutbphysicianbsupervision.
DIF: CognitivebLevel:bUnderstandingb(Comprehension) REF:b 9
2. CRNAsbinbmostbstates:
a. mustbhavebabDrugbEnforcementbAdministrati
onb(DEA)bnumberbtobpractice.
b. mustbhavebprescriptivebauthoritybtob
practice.
c. orderbandbadministerbcontrolledbsubstancesb
butbdobnotbhavebfullbprescriptivebauthority.
d. administerbmedications,bincludingbc
ontrolledbsubstances,bunderbdirectbp
hysicianbsupervision.
ANS:b C
OnlybfivebstatesbgrantbindependentbprescriptivebauthoritybtobCRNAs.bCRNAsbdobnotbrequireb
prescriptivebauthoritybbecausebtheybdispensebabdrugbimmediatelybtobabpatientbandbdobnotbpr
escribe.bWithoutbprescriptivebauthority,b theybdobnotbneedbabDEAbnumber.
DIF: CognitivebLevel:bUnderstandingb(Comprehension) REF:b 9
3. AbCNM:
a. maybtreatbonlybwomen.
b. hasbprescriptivebauthoritybinballb50bstates.
c. maybadministerbonlybdrugsbusedbduringbl
aborbandbdelivery.
d. maybpracticebonlybinbbirthingbcentersbandbh
omebbirthbsettings.
ANS:b B
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
7
, CNMsbhavebprescriptivebauthoritybinballb50bstates.bTheybmaybtreatbpartnersbofbwomenbforbse
xuallybtransmittedbdiseases.bTheybhavebfullbprescriptivebauthoritybandbarebnotblimitedbtobdru
gsbusedbduringbchildbirth.bTheybpracticebinbmanybotherbtypesbofbsettings.
DIF: CognitivebLevel:bRememberingb(Knowledge) REF:b 9
4. Inbeverybstate,bprescriptivebauthoritybforbNPsbincludesbthebabilitybtobwritebprescriptions:
a. forbcontrolledbsubstances.
b. forbspecifiedbclassificationsbofb
medications.
c. withoutbphysician-mandatedbinvolvement.
d. withbfull,bindependentbprescriptiveb
authority.
ANS:b B
AllbstatesbnowbhavebsomebdegreebofbprescriptivebauthoritybgrantedbtobNPs,bbutbnotballbstatesb
allowbauthoritybtobprescribebcontrolledbsubstances.bManybstatesbstillbrequirebsomebdegreebofb
physicianbinvolvementb withbcertainbtypesbofbdrugs.
DIF: CognitivebLevel:bUnderstandingb(Comprehension) REF:b 12
5. ThebcurrentbtrendbtowardbtransitioningbNPbprogramsbtobthebdoctoralblevelbwillbmeanbthat:
a. NPsblicensedbinbonebstatebmaybpracticebinbo
therbstates.
b. fullbprescriptivebauthoritybwillbbebgrantedbt
oballbNPsbwithbdoctoralbdegrees.
c. NPsbwillbbebbetterbpreparedbtobmeetbe
mergingbhealthbcarebneedsbofbpatients.
d. requirementsbforbphysicianbsupervisionbofbN
Psbwillbbebremovedbinballbstates.
ANS:b C
ThebAmericanbAssociationbofbCollegesbofbNursingbhasbrecommendedbtransitioningbgraduatebl
evelbNPbprogramsbtobthebdoctoralblevelbasbabresponsebtobchangesbinbhealthbcarebdeliveryban
dbemergingbhealthbcarebneeds.bNPsbwithbdoctoralbdegreesbwillbnotbnecessarilybhaveb fullbpres
criptivebauthorityborbbebfreedb frombrequirementsbaboutb physicianbsupervisionbbecausebthoseb
arebsubjectbtobindividualbstateblaws.bNPsbwillbstillbbebrequiredbtobmeetblicensurebrequirementsb
ofbeachbstate.
DIF: CognitivebLevel:bUnderstandingb(Comprehension) REF:b 12
6. Anbimportantbdifferencebbetweenbphysicianbassistantsb(PAs)bandbNPsbisbPAs:
a. alwaysbworkbunderbphysicianbsupervision.
b. arebnotbrequiredbtobfollowbdrugbtreatment
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
8
, protocols.
c. maybwritebforballbdrugbcategoriesbwithb
physicianbco-signatures.
d. havebbothbinpatientbandboutpatientb
independentbprescriptivebauthority.
ANS:b A
PAsbcommonlybhavebco-signaturebrequirementsbandbworkbunderbphysicianbsupervision.
DIF: CognitivebLevel:bUnderstandingb(Comprehension)
REF:b17bChapterb03:bGeneralbPharmacokineticbandbPharmacodyn
amic PrinciplesTest Bank
b b b
MULTIPLEbCHOICE
1. Abprimarybcarebnursebpractitionerb(NP)bprescribesbabdrugbtobanb80-year-oldbAfrican-
Americanbwoman.bWhenbselectingbabdrugbandbdeterminingbthebcorrectbdose,bthebNPbsh
b
ouldbunderstandbthatbthebknowledgebofbhowbage,brace,bandbgenderbmaybaffectbdrugbe
xcretionbisbbasedbonbanbunderstandingbof:
a. bioavailability.
b. pharmacokinetics.
c. pharmacodynamics.
d. anatomybandbphysiology.
ANS:b B
Pharmacokineticsbisbthebstudybofbthebactionbofbdrugsbinbthebbodybandbmaybbebthoughtbofbasbw
hatbthebbodybdoesbtobthebdrug.bFactorsbsuchbasbage,brace,bandbgenderbmaybchangebthebwayb
thebbodybactsbtobmetabolizebandbexcretebabdrug.bBioavailabilitybrefersbtobthebamountbofbdru
gbavailablebatbthebsitebofbaction.bPharmacodynamicsbisbthebstudybofbthebeffectsbofbdrugsbonbt
hebbody.bAnatomybandbphysiologybisbabbasicbunderstandingbofbhowbthebbodybfunctions.
DIF: CognitivebLevel:bUnderstandingb(Comprehension) REF:b 21
2. AbpatientbasksbthebprimarybcarebNPbwhichbmedicationbtobusebforbmildbtobmoderatebpain.bTh
ebNPbshouldbrecommend:
a. APAP.
b. Tylenol.
c. acetaminophen.
d. anybover-the-counterbpainbproduct.
ANS:b C
Providersbshouldbusebgenericbdrugbnamesbwhenbprescribingbdrugsborbrecommendingbthem
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
9
, tobpatients,bunlessbabparticularbbrandbisbessentialbforbsomebreason.bBecausebacetaminophenbc
anbhavebmanybtradebnames,bitbisbimportantbforbpatientsbtobunderstandbthatbthebdrugbisbthebsa
mebforballbtobavoidboverdosingbonbacetaminophen.bAPAPb isbabcommonlybusedbabbreviationbb
utbshouldbnotbbebusedbwhenbrecommendingbthebdrugbtobpatients.
DIF: CognitivebLevel:bApplyingb(Application) REF:b 21
3. Abpatientbwantsbtobknowbwhybabcheaperbversionbofbabdrugbcannotbbebusedbwhenbthebprim
arybcarebNPbwritesbabprescriptionbforbabspecificbbrandbnamebofbthebdrugbandbwrites,b“Disp
ensebasbWritten.”bThebNPbshouldbexplainbthatbabdifferentbbrandbofbthisbdrug:
a. maybcausebdifferentbadversebeffects.
b. doesbnotbnecessarilybhavebthebsamebt
herapeuticbeffect.
c. isblikelybtobbeblessbsafebthanbthebbrandbs
pecifiedbinbthebprescription.
d. maybvarybinbthebamountbofbdrugbthatbr
eachesbthebsitebofbactionbinbthebbody.
ANS:b D
Differentbformulationsbofbthebsamebdrugbmaybhavebvaryingbdegreesbofbbioavailability,bandbit
bmaybbebimportantbtobstickbtobabparticularbbrandbforbdrugsbwithbnarrowbtherapeuticbranges.b
Allbdrugsbwithbsimilarbactivebingredientsbshouldbhavebthebsamebtherapeuticbactionsbandbsidebef
fectsbandbshouldbbebequallybsafe.
DIF: CognitivebLevel:bApplyingb(Application) REF:b 22
4. AbprimarybcarebNPbwishesbtoborderbabdrugbthatbwillbbebeffectivebimmediatelybafterba
dministrationbofbthebdrug.bWhichbroutebshouldbthebNPbchoose?
a. Rectal
b. Topical
c. Sublingual
d. Intramuscular
ANS:b C
Thebsublingualbroutebisbpreferredbforbquickbactionbbecausebthebdrugbisbdirectlybabsorbedbinto
bthebbloodstreambandbavoidsbthebpassbthroughbofbthebliver,bwhereb muchbofbanboralbdrugb
isbmet
abolized.bRectalbroutesbhavebunpredictablebabsorptionbrates.bTopicalbroutesbarebthebslowest.
bIntramuscularb routesbarebslow.
DIF: CognitivebLevel:bRememberingb(Knowledge) REF:b 22
5. Abpatientbreceivesbanbinhaledbcorticosteroidbtobtreatbasthma.bThebpatientbasksbthebprimarybc
arebNPbwhybthebdrugbisbgivenbbybthisbroutebinsteadbofborally.bThebNPbshouldbexplainbthatbthebi
nhaledbform:
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
10
b b b b b b b b b b b
ition by Zambroski & Rebecca M Lutz | Verified Chapter's 1 -
b b b b b b b b b b b
b73 | Complete Newest Version
b b b b
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
1
,TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
2
,TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
3
,TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
4
,Chapter 01: Prescriptive Authority and Role Implementation: Tradition vs. ChangeTest B
b b b b b b b b b b b
ank
MULTIPLEbCHOICE
1. bWhichbofbthebfollowingbhasbinfluencedbanbemphasisbonbprimarybcarebeducationbinbmedicalbsc
hools?
a. ChangesbinbMedicarebreimbursementb
methodsbrecommendedbinb1992
b. Competitionbfrombnonphysiciansbdesiringbto
bmeetb primarybcarebshortages
c. Thebneedbforbmonopolisticbcontrolbinbthebm
arketplacebofbprimaryboutpatientbcare
d. Thebrecognitionbthatbnonphysiciansbhavebv
ariablebsuccessbprovidingbprimarybcare
ANS:b A
ThebPhysicianbPaymentbReviewbCommissionbinb1992bdirectlybincreasedbfinancialbreimbursem
entbtobcliniciansbwhobprovidebprimarybcare.bCoupledbwithbabshortagebofbprimarybcarebprovid
ers,bthisbincentivebledbmedicalbschoolsbtobplacebgreaterbemphasisbonbpreparingbprimarybcareb
physicians.bCompetitionbfrombnonphysiciansbincreasedbcoincidentallybasbprofessionalsbfrombo
therbdisciplinesbsteppedbupbtobmeetbthebneeds.
Nonphysiciansbhavebhadbincreasingbsuccessbatbprovidingbprimarybcarebandbhavebbeenbshownb
tobbebsafebandbeffective.
DIF: CognitivebLevel:bRememberingb(Knowledge) REF:b 2
2. Whichbofbthebfollowingbstatementsbisbtruebaboutbthebprescribingbpracticesbofbphysicians?
a. Olderbphysiciansbtendbtobprescribebmoreb
appropriatebmedicationsbthanbyoungerb
physicians.
b. Antibioticbmedicationsbremainbinbthebtopbfi
vebclassificationsbofbmedicationsbprescrib
ed.
c. Mostbphysiciansbrelybonbab“therapeuticbarm
amentarium”bthatbconsistsbofblessbthan
100bdrugbpreparationsbperbphysician.
d. Thebdominantbformbofbdrugbinformationbuse
dbbybprimarybcarebphysiciansbcontinuesbtobb
ebthatbprovidedbbybpharmaceuticalbcompa
nies.
ANS:b D
Evenbthoughbmostbphysiciansbclaimbtobplaceblittlebweightbonbdrugbadvertisements,
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
5
, pharmaceuticalbrepresentatives,bandbpatientbpreferencebandbstatebthatbtheybrelybonbacade
micbsourcesbforbdrugbinformation,babstudybshowedbthatbcommercialbratherbthanbscientificbsourc
esbofbdrugbinformationbdominatedbtheirbdrugbinformationbmaterials.bYoungerbphysiciansbtendb
tobprescribebfewerbandbmorebappropriatebdrugs.bAntibioticsbhavebdroppedboutbofbthebtopbfiv
ebclassificationsbofbdrugsbprescribed.bMostbphysiciansbhavebabtherapeuticbarmamentariumbofb
aboutb144bdrugs.
DIF: CognitivebLevel:bRememberingb(Knowledge) REF:b 3
3. Asbprimarybcarebnursebpractitionersb(NPs)bcontinuebtobdevelopbtheirbrolebasbprescribersbofbm
edications,bitbwillbbebimportantbto:
a. attainbthebsameblevelbofbexpertisebasb
physiciansb whob currentlybprescribe
medications.
b. learnbfrombthebexperiencesbofbphysiciansb
andbdevelopbexpertisebbasedbonbevidence
-bbasedbpractice.
c. maintainbcollaborativebandbsupervisorialbr
elationshipsbwithbphysiciansbwhobwillbover
seebprescribingbpractices.
d. developbrelationshipsbwithbpharmaceuticalbr
epresentativesbtoblearnbaboutbnewbmedicat
ionsbasbtheybarebdeveloped.
ANS:b B
Asbnonphysiciansbdevelopbthebrolesbassociatedbwithbprescriptivebauthority,bitbwillbbebimporta
ntbtoblearnbfrombthebpastbexperiencesbofbphysiciansbandbtobdevelopbprescribingbpracticesbba
sedbonbevidence-
basedbmedicine.bItbisbhopedbthatballbprescribers,bincludingbphysiciansbandbnursebpractitioners,
bwillbstrivebtobdobbetterbthanbinbthebpast.bNPsbshouldbworkbtowardbprescriptivebauthoritybandbf
orbpracticebthatbisbnotbsupervisedbbybanotherbprofessional.bPharmaceuticalbrepresentativesbp
rovidebinformationbthatbcarriesbsomebbias.bAcademicbsourcesbarebbetter.
DIF: CognitivebLevel:bApplyingb(Application) REF:b4
Chapter 02: Historical Review of Prescriptive Authority: The Role of Nurses (NPs,CNMs,
b b b b b b b b b b b b b
CRNAs, and CNSs) and Physician Assistants
b b b b b
Test Bank
b
MULTIPLEbCHOICE
1. AbprimarybcarebNPbwillbbeginbpracticingbinbabstatebinbwhichbthebgovernorbhasboptedboutbofbth
ebfederalbfacilitybreimbursementbrequirement.bThebNPbshouldbbebawarebthatbthisbdefinesbhow
bNPsbmaybwritebprescriptions:
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
6
, a. withoutbphysicianbsupervisionbinbprivatebpr
actice.
b. asbCRNAsbwithoutbphysicianbsupervisionbinb
abhospitalbsetting.
c. inbanybsituationbbutbwillbnotbbebreimbursedbf
orbthisbbybgovernmentb insurers.
d. onlybwithbphysicianbsupervisionbinbbothbpri
vatebpracticebandbabhospitalbsetting.
ANS:b B
Inb2001,bthebCentersbforbMedicarebandbMedicaidbServicesbchangedbthebfederalbphysicianbsu
pervisionbrulebforbCRNAsbtoballowbstatebgovernorsbtoboptbout,ballowingbCRNAsbtobwritebprescri
ptionsbandbdispensebdrugsbwithoutbphysicianbsupervision.
DIF: CognitivebLevel:bUnderstandingb(Comprehension) REF:b 9
2. CRNAsbinbmostbstates:
a. mustbhavebabDrugbEnforcementbAdministrati
onb(DEA)bnumberbtobpractice.
b. mustbhavebprescriptivebauthoritybtob
practice.
c. orderbandbadministerbcontrolledbsubstancesb
butbdobnotbhavebfullbprescriptivebauthority.
d. administerbmedications,bincludingbc
ontrolledbsubstances,bunderbdirectbp
hysicianbsupervision.
ANS:b C
OnlybfivebstatesbgrantbindependentbprescriptivebauthoritybtobCRNAs.bCRNAsbdobnotbrequireb
prescriptivebauthoritybbecausebtheybdispensebabdrugbimmediatelybtobabpatientbandbdobnotbpr
escribe.bWithoutbprescriptivebauthority,b theybdobnotbneedbabDEAbnumber.
DIF: CognitivebLevel:bUnderstandingb(Comprehension) REF:b 9
3. AbCNM:
a. maybtreatbonlybwomen.
b. hasbprescriptivebauthoritybinballb50bstates.
c. maybadministerbonlybdrugsbusedbduringbl
aborbandbdelivery.
d. maybpracticebonlybinbbirthingbcentersbandbh
omebbirthbsettings.
ANS:b B
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
7
, CNMsbhavebprescriptivebauthoritybinballb50bstates.bTheybmaybtreatbpartnersbofbwomenbforbse
xuallybtransmittedbdiseases.bTheybhavebfullbprescriptivebauthoritybandbarebnotblimitedbtobdru
gsbusedbduringbchildbirth.bTheybpracticebinbmanybotherbtypesbofbsettings.
DIF: CognitivebLevel:bRememberingb(Knowledge) REF:b 9
4. Inbeverybstate,bprescriptivebauthoritybforbNPsbincludesbthebabilitybtobwritebprescriptions:
a. forbcontrolledbsubstances.
b. forbspecifiedbclassificationsbofb
medications.
c. withoutbphysician-mandatedbinvolvement.
d. withbfull,bindependentbprescriptiveb
authority.
ANS:b B
AllbstatesbnowbhavebsomebdegreebofbprescriptivebauthoritybgrantedbtobNPs,bbutbnotballbstatesb
allowbauthoritybtobprescribebcontrolledbsubstances.bManybstatesbstillbrequirebsomebdegreebofb
physicianbinvolvementb withbcertainbtypesbofbdrugs.
DIF: CognitivebLevel:bUnderstandingb(Comprehension) REF:b 12
5. ThebcurrentbtrendbtowardbtransitioningbNPbprogramsbtobthebdoctoralblevelbwillbmeanbthat:
a. NPsblicensedbinbonebstatebmaybpracticebinbo
therbstates.
b. fullbprescriptivebauthoritybwillbbebgrantedbt
oballbNPsbwithbdoctoralbdegrees.
c. NPsbwillbbebbetterbpreparedbtobmeetbe
mergingbhealthbcarebneedsbofbpatients.
d. requirementsbforbphysicianbsupervisionbofbN
Psbwillbbebremovedbinballbstates.
ANS:b C
ThebAmericanbAssociationbofbCollegesbofbNursingbhasbrecommendedbtransitioningbgraduatebl
evelbNPbprogramsbtobthebdoctoralblevelbasbabresponsebtobchangesbinbhealthbcarebdeliveryban
dbemergingbhealthbcarebneeds.bNPsbwithbdoctoralbdegreesbwillbnotbnecessarilybhaveb fullbpres
criptivebauthorityborbbebfreedb frombrequirementsbaboutb physicianbsupervisionbbecausebthoseb
arebsubjectbtobindividualbstateblaws.bNPsbwillbstillbbebrequiredbtobmeetblicensurebrequirementsb
ofbeachbstate.
DIF: CognitivebLevel:bUnderstandingb(Comprehension) REF:b 12
6. Anbimportantbdifferencebbetweenbphysicianbassistantsb(PAs)bandbNPsbisbPAs:
a. alwaysbworkbunderbphysicianbsupervision.
b. arebnotbrequiredbtobfollowbdrugbtreatment
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
8
, protocols.
c. maybwritebforballbdrugbcategoriesbwithb
physicianbco-signatures.
d. havebbothbinpatientbandboutpatientb
independentbprescriptivebauthority.
ANS:b A
PAsbcommonlybhavebco-signaturebrequirementsbandbworkbunderbphysicianbsupervision.
DIF: CognitivebLevel:bUnderstandingb(Comprehension)
REF:b17bChapterb03:bGeneralbPharmacokineticbandbPharmacodyn
amic PrinciplesTest Bank
b b b
MULTIPLEbCHOICE
1. Abprimarybcarebnursebpractitionerb(NP)bprescribesbabdrugbtobanb80-year-oldbAfrican-
Americanbwoman.bWhenbselectingbabdrugbandbdeterminingbthebcorrectbdose,bthebNPbsh
b
ouldbunderstandbthatbthebknowledgebofbhowbage,brace,bandbgenderbmaybaffectbdrugbe
xcretionbisbbasedbonbanbunderstandingbof:
a. bioavailability.
b. pharmacokinetics.
c. pharmacodynamics.
d. anatomybandbphysiology.
ANS:b B
Pharmacokineticsbisbthebstudybofbthebactionbofbdrugsbinbthebbodybandbmaybbebthoughtbofbasbw
hatbthebbodybdoesbtobthebdrug.bFactorsbsuchbasbage,brace,bandbgenderbmaybchangebthebwayb
thebbodybactsbtobmetabolizebandbexcretebabdrug.bBioavailabilitybrefersbtobthebamountbofbdru
gbavailablebatbthebsitebofbaction.bPharmacodynamicsbisbthebstudybofbthebeffectsbofbdrugsbonbt
hebbody.bAnatomybandbphysiologybisbabbasicbunderstandingbofbhowbthebbodybfunctions.
DIF: CognitivebLevel:bUnderstandingb(Comprehension) REF:b 21
2. AbpatientbasksbthebprimarybcarebNPbwhichbmedicationbtobusebforbmildbtobmoderatebpain.bTh
ebNPbshouldbrecommend:
a. APAP.
b. Tylenol.
c. acetaminophen.
d. anybover-the-counterbpainbproduct.
ANS:b C
Providersbshouldbusebgenericbdrugbnamesbwhenbprescribingbdrugsborbrecommendingbthem
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
9
, tobpatients,bunlessbabparticularbbrandbisbessentialbforbsomebreason.bBecausebacetaminophenbc
anbhavebmanybtradebnames,bitbisbimportantbforbpatientsbtobunderstandbthatbthebdrugbisbthebsa
mebforballbtobavoidboverdosingbonbacetaminophen.bAPAPb isbabcommonlybusedbabbreviationbb
utbshouldbnotbbebusedbwhenbrecommendingbthebdrugbtobpatients.
DIF: CognitivebLevel:bApplyingb(Application) REF:b 21
3. Abpatientbwantsbtobknowbwhybabcheaperbversionbofbabdrugbcannotbbebusedbwhenbthebprim
arybcarebNPbwritesbabprescriptionbforbabspecificbbrandbnamebofbthebdrugbandbwrites,b“Disp
ensebasbWritten.”bThebNPbshouldbexplainbthatbabdifferentbbrandbofbthisbdrug:
a. maybcausebdifferentbadversebeffects.
b. doesbnotbnecessarilybhavebthebsamebt
herapeuticbeffect.
c. isblikelybtobbeblessbsafebthanbthebbrandbs
pecifiedbinbthebprescription.
d. maybvarybinbthebamountbofbdrugbthatbr
eachesbthebsitebofbactionbinbthebbody.
ANS:b D
Differentbformulationsbofbthebsamebdrugbmaybhavebvaryingbdegreesbofbbioavailability,bandbit
bmaybbebimportantbtobstickbtobabparticularbbrandbforbdrugsbwithbnarrowbtherapeuticbranges.b
Allbdrugsbwithbsimilarbactivebingredientsbshouldbhavebthebsamebtherapeuticbactionsbandbsidebef
fectsbandbshouldbbebequallybsafe.
DIF: CognitivebLevel:bApplyingb(Application) REF:b 22
4. AbprimarybcarebNPbwishesbtoborderbabdrugbthatbwillbbebeffectivebimmediatelybafterba
dministrationbofbthebdrug.bWhichbroutebshouldbthebNPbchoose?
a. Rectal
b. Topical
c. Sublingual
d. Intramuscular
ANS:b C
Thebsublingualbroutebisbpreferredbforbquickbactionbbecausebthebdrugbisbdirectlybabsorbedbinto
bthebbloodstreambandbavoidsbthebpassbthroughbofbthebliver,bwhereb muchbofbanboralbdrugb
isbmet
abolized.bRectalbroutesbhavebunpredictablebabsorptionbrates.bTopicalbroutesbarebthebslowest.
bIntramuscularb routesbarebslow.
DIF: CognitivebLevel:bRememberingb(Knowledge) REF:b 22
5. Abpatientbreceivesbanbinhaledbcorticosteroidbtobtreatbasthma.bThebpatientbasksbthebprimarybc
arebNPbwhybthebdrugbisbgivenbbybthisbroutebinsteadbofborally.bThebNPbshouldbexplainbthatbthebi
nhaledbform:
TestbBankb-bPharmacologybforbthebPrimarybCarebProvider,b5thbEditionb(Edmunds),bChapterb1-73
10
